25 March 2006

Contents

Conference reports

• Early integrase inhibitor studies in treatment experienced patients raise hopes for new drugs in a new class

• Atazanavir in treatment naive patients, with and without ritonavir boosting

• Simplification to atazanavir/ritonavir monotherapy

• Summary of STI studies: SMART shows clear increased risk from interrupting treatment at any CD4 count

• The effect of repeated single-dose nevirapine for PMTCT in a second pregnancy

• Should criteria for initiation of HAART be revisited in pregnant women?

• Cotrimoxazole prophylaxis in pregnancy

• Treatment in primary HIV infection

• CNS penetration of ARV drugs is associated with lower CSF viral load

• Sexual transmission of hepatitis C in HIV-positive men in the UK

• D:A:D study shows that PIs rather than NNRTIs drive the previously reported cardiovascular risk of combination antiretroviral therapy

• Interventions for the management of lipodystrophy and metabolic complications